Intradermal Lidocaine Injection in Pregnancy
Intradermal lidocaine injection is safe for use during pregnancy in small amounts, but elective procedures should be postponed until after delivery, and urgent procedures should ideally be delayed until at least the second trimester. 1
Safety Profile
Lidocaine is classified as FDA Pregnancy Category B, meaning animal studies have shown no evidence of harm to the fetus at doses up to 5 times the human dose, though adequate controlled studies in pregnant women are lacking 2. The American Academy of Dermatology guidelines specifically state that topical and infiltrative lidocaine is safe for use in pregnant women when used in small amounts 1.
Clinical Recommendations - Algorithmic Approach
For Elective Procedures:
- Postpone until after delivery to avoid any unnecessary fetal exposure 1
- This applies to cosmetic procedures, benign lesion removal, and non-urgent biopsies
For Urgent Medical Necessity:
- Delay until second trimester when possible 1
- First trimester organogenesis carries theoretical risk
- Second trimester is the optimal window for necessary procedures 3
For Emergency/Cannot Delay:
- Proceed with small amounts of lidocaine (manufacturer recommends maximum 4.5 mg/kg without epinephrine, 7 mg/kg with epinephrine) 1
- Use the minimum effective dose
- Consider consultation with patient's obstetrician for large procedures requiring substantial anesthesia volumes 1
Important Considerations About Epinephrine
Epinephrine is FDA Pregnancy Category C (versus lidocaine's Category B), but when used in small amounts with lidocaine for dermatologic surgery, the benefits appear to outweigh risks 1. The local vasoconstriction from epinephrine actually limits maternal blood levels and placental transfer of lidocaine 1. However, one study suggested increased malformations with first-trimester systemic epinephrine exposure 1.
Epinephrine Decision Algorithm:
- Avoid in first trimester elective cases - postpone procedure
- Can use in second/third trimester for urgent procedures in small amounts
- Benefits: Reduced systemic lidocaine absorption, prolonged anesthesia duration, improved hemostasis
Common Pitfalls to Avoid
Don't assume all local anesthetics are equal: Only lidocaine has sufficient safety data in pregnancy. Other topical anesthetics lack evidence and should be avoided 1
Don't exceed recommended doses: Lidocaine readily crosses the placental barrier 2. Stick to minimum effective volumes
Don't forget timing matters: Second trimester is safest for necessary procedures - avoid first trimester organogenesis period and late third trimester when possible 1, 3
Don't use for melanoma/high-risk cancers: These should never be delayed regardless of trimester - proceed immediately with appropriate anesthesia 3
Strength of Evidence
The guideline recommendations are based on Level III evidence (expert opinion) with Strength C recommendations 1. While not the highest level of evidence, this reflects the ethical impossibility of conducting randomized trials in pregnant women. The consistent expert consensus, FDA Category B rating, and animal safety data at 5x human doses provide reasonable assurance of safety when used appropriately 1, 2.
Real-world clinical experience supports safety: a 2019 review confirmed lidocaine and epinephrine can be used safely in pregnant patients undergoing dermatologic surgery 3, and animal studies showed no teratogenic effects 4.